Roszet® (rosuvastatin and ezetimibe) tablets is now approved by FDA in United States and is expected to be available to patients in June 2021.
Please read more at www.roszet.com
Please read full Prescribing information at roszet.com/pi.
Rosuvastatin/Ezetimibe tablets are also approved in 28 countries worldwide. Althera makes the product available to patients in these markets through local and regional partnerships.
Ezetimibe/Atorvastatin tablets are currently approved in the United States by the US FDA and in several European countries. We anticipate the product to be made available to patients during calendar year 2021.